QSAM — Qsam Biosciences Cashflow Statement
0.000.00%
Last trade - 00:00- $35.56m
- $34.18m
Annual cashflow statement for Qsam Biosciences, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | C2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -0.682 | -4.86 | -12 | -5.48 | -4.39 |
| Depreciation | |||||
| Non-Cash Items | -0.364 | 3.79 | 10 | 2.03 | 1.69 |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.068 | 0.328 | 0.209 | 0.742 | -0.144 |
| Change in Prepaid Expenses | |||||
| Change in Accrued Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -0.978 | -0.743 | -1.73 | -2.71 | -2.85 |
| Other Investing Cash Flow Items | 0 | — | — | — | — |
| Sale/Maturity of Investment | |||||
| Cash from Investing Activities | 0 | — | — | — | — |
| Financing Cash Flow Items | — | — | -0.035 | 0.035 | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 0.819 | 0.751 | 3.23 | 1.44 | 4.01 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -0.16 | 0.008 | 1.49 | -1.27 | 1.16 |